Pasquale Innominato

16PUBLICATIONS
88CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)RehabilitationHealth informatics and information systemsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Dec 15, 2025
Timing of Immunotherapy in Practice: Feasibility and Impact of Morning Checkpoint Inhibitor Administration.

Pasquale F Innominato, Thierry Landré, Abdoulaye Karaboué

|Jun 04, 2024
Why does circadian timing of administration matter for immune checkpoint inhibitors' efficacy?

Abdoulaye Karaboué, Pasquale F Innominato, Nicholas I Wreglesworth

|Apr 30, 2024
Digital Remote Monitoring Using an mHealth Solution for Survivors of Cancer: Protocol for a Pilot Observational Study.

Pasquale F Innominato, Jamie H Macdonald, Wendy Saxton

|Jun 28, 2023
GATEKEEPER's Strategy for the Multinational Large-Scale Piloting of an eHealth Platform: Tutorial on How to Identify Relevant Settings and Use Cases.

Jordi de Batlle, Ivan D Benítez, Anna Moncusí-Moix

|Sep 26, 2022
Holistic Needs Assessment of Cancer Survivors-Supporting the Process Through Digital Monitoring of Circadian Physiology.

Max Gibb, Hannah Winter, Sandra Komarzynski

|May 08, 2021
Impact of assessment frequency of patient-reported outcomes: an observational study using an eHealth platform in cancer patients.

Pasquale F Innominato, Sandra Komarzynski, Robert Dallmann

Pageof 3

Frequent Collaborators

7 joint publications

Francis Levi

5 joint publications

Abdoulaye Karaboué

4 joint publications

Sandra Komarzynski

4 joint publications

Christian Subbe